This milestone fulfills the strategic vision behind StatLab’s 2024 acquisition of Diapath: to bring differentiated histology instrumentation to U.S. laboratories and deliver a comprehensive end-to-end pathology workflow solution.
These highly innovative instruments—designed to enhance productivity, precision, and safety—will debut at the National Society of Histotechnology (NSH) Annual Convention, where laboratory professionals will experience them firsthand.
Advancing innovation across the pathology workflow, the flagship instruments include:
- Donatello Automated Tissue Processor (Series 3): Delivering consistent quality, safer handling, and high-capacity performance for busy labs.
- Galileo Precision-Engineered Microtome (Series 2): Built for labs that demand accuracy and user flexibility while also offering increased throughput using the PRO System.
- Dante Ergonomic Embedding Center: Designed to boost technician comfort and efficiency with industry-leading capacity.
“When we acquired Diapath, our vision was clear: to expand access to the most innovative histology instrumentation worldwide,” said Dae Hong, StatLab CEO. “That meant strengthening our footprint in Europe while also preparing to introduce Diapath instruments to laboratories in the United States. With the launch of these initial instruments in the U.S., we are delivering on that promise—giving lab professionals access to new technology that transforms efficiency, precision, and the day-to-day working experience. And this is just the beginning—additional Diapath products will follow, further expanding StatLab’s ability to support every step of the pathology workflow.”
Attendees of the NSH Convention are invited to visit the StatLab booth to see live demonstrations of the Donatello, Galileo, and Dante, and learn how these innovations can elevate laboratory performance.
About StatLab Medical Products
StatLab Medical Products has been dedicated to helping anatomic pathology laboratories provide the best possible patient care since 1976. We offer a complete portfolio of self-manufactured pathology equipment and consumables from ten manufacturing sites in the United States, United Kingdom, and Europe. Our global operational footprint powered by over 800 mission-driven colleagues delivers a dependable and resilient supply chain of high-quality products and solutions, and a customer-centric approach inspires us to deliver reliability, innovation, and quality in every interaction.
For more information please visit, www.StatLab.com.
